Chartwell Investment Partners’s Array Biopharma Inc ARRY Stock Holding History

Chartwell Investment Partners’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-71,475	Closed	-$3.31M	–	432
2019 Q2	$3.31M	Buy	+71,475	New	+$2.01M	0.11%	263
2013 Q4	–	Sell	-17,000	Closed	-$106K	–	379
2013 Q3	$106K	Sell	17,000 -761,655	-98%	-$4.52M	﹤0.01%	352
2013 Q2	$3.54M	Buy	+778,655	New	+$4.19M	0.09%	267

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Chartwell Investment Partners's ARRY Position: Q3 2019 in Review

Chartwell Investment Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 71,475 shares — an estimated $3.31M sold.

Chartwell Investment Partners first reported a position in ARRY in Q2 2013 and held it in 3 quarters. The position peaked at $3.54M in Q2 2013. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Chartwell Investment Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Chartwell Investment Partners sold 71,475 Array Biopharma Inc shares in Q3 2019, an estimated $3.31M.
Chartwell Investment Partners first reported a position in Array Biopharma Inc in Q2 2013 and held it in 3 quarters.
Chartwell Investment Partners's Array Biopharma Inc position peaked at $3.54M in Q2 2013.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Chartwell Investment Partners's 13F filing for Q3 2019, filed 29 Oct 2019.